Solesence (SLSN) Cash & Equivalents (2010 - 2026)

Solesence has reported Cash & Equivalents for 17 years, with the latest figure at $573000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 68.46% year-over-year to $573000.0; the trailing twelve-month figure through Mar 2026 stood at $573000.0 (down 68.46% YoY), and the FY2025 full-year result was $1.3 million, down 8.59% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $573000.0, down from $1.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $4.1 million in Q2 2025, with the low at $429000.0 in Q3 2025.
• Historically, Cash & Equivalents has averaged $1.6 million across 5 years, with a median of $1.4 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 232.72% — and 2025, when it sank 85.33%.
• Solesence's Cash & Equivalents stood at $2.2 million in 2022, then declined by 21.23% to $1.7 million in 2023, then retreated by 18.18% to $1.4 million in 2024, then decreased by 8.59% to $1.3 million in 2025, then slumped by 55.51% to $573000.0 in 2026.
• The last three Cash & Equivalents figures came in at $573000.0 (Q1 2026), $1.3 million (Q4 2025), and $429000.0 (Q3 2025), per Business Quant data.